Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion

Planned Parenthood Shows $¾ Billion of Excess of Revenue Over Past Decade

As debate over the relative capacity of Planned Parenthood clinics and federally qualified health centers has emerged, one element of the argument has focused on funds that may be available to the former to replace certain government grants and reimbursements.  CLI examined nine consecutive years of annual reports for the organization and the available information there on “excess of revenue over expenses” is shown below.  While consistent details on certain financials in these documents are absent, particularly prior to 2008, the annual reports provide a glimpse of the general pattern of net income for the organization over nearly a full decade:

 

To download as PDF with clickable links, please see “Planned Parenthood Excess Revenue, 2005-2014“

 

 Science Behind Embryonic Heartbeats - Fact Sheet
.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Abortion Reporting: Kentucky (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Alabama (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Virginia (2024)

October 5, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image